Two-wheeler market leader Hero MotoCorp on Friday said it will resume partial operations at its three plants at Gurugram and Dharuhera in Haryana and Haridwar in Uttarakhand from May 17. The company had halted operations temporarily at its six plants in India in a staggered manner for four days from April 22 to May 2, which was then extended till May 16. In a statement, Hero MotoCorp said it is “gearing up towards a gradual resumption of operations by starting single shift production at three of its plants Gurugram and Dharuhera in Haryana and at Haridwar in the northern hill state of Uttarakhand from Monday.”
Besides producing for the domestic market in India, these plants will also have enhanced focus on catering to the global markets, it added. On resumption of production at the other plants, the company said it “continues to monitor the situation closely and the remaining manufacturing plants and other facilities will also open up gradually”. On Sunday the company had announced that it is extending the shutdown of all its plants across India by another week till May 16 in view of the prevailing COVID-19 situation in the country.
The shutdown also included the Global Parts Center (GPC) in Neemrana and R&D facility the Centre of Innovation and Technology (CIT) in Jaipur. Last month, the company had announced temporary stopping of operations at all its six manufacturing units located at Dharuhera and Gurugram, Haryana; Chittoor in Andhra Pradesh; Haridwar in Uttarakhand; Neemrana in Rajasthan, and Halol in Gujarat with a total yearly production capacity of 90 lakh units.
Commenting on the COVID-19 vaccination of its employees, Hero MotoCorp said more than 90 per cent of its employees above the age of 45 have already been vaccinated. “Strict safety and hygiene protocols are in place at all plant locations and offices in preparation for the gradual resumption of operations,” the company said adding, all of its corporate offices have already been in work from home mode.
Read all the Latest News, Breaking News and Coronavirus News here. Follow us on Facebook, Twitter and Telegram.
Comments
0 comment